Search Results

You are looking at 1 - 4 of 4 items for

  • Author: SG Hillier x
  • Refine by access: All content x
Clear All Modify Search
K.E. Hudson
Search for other papers by K.E. Hudson in
Google Scholar
PubMed
Close
and
S.G. Hillier
Search for other papers by S.G. Hillier in
Google Scholar
PubMed
Close

ABSTRACT

Catechol oestrogens are formed in the ovary but it is not known if they have a local function. Working with primary granulosa cell cultures prepared from immature rat ovaries, we found that the presence of 2-hydroxyoestradiol in the culture medium (48 h incubation) dramatically enhanced the steroidogenic response (progesterone production) to human FSH (100 ng/ml). The effect of 2-hydroxyoestradiol was dose-dependent and maximal (approximately 40 times the response to FSH alone) at 3.0 μM. The stimulatory action of 1.0 μM 2-hydroxyoestradiol was >10 times more than that of 1.0 μM oestradiol but only half that of 1.0 μM testosterone; other catechol oestrogens (2-hydroxyoestrone, 4-hydroxyoestradiol, 2-methoxyoestradiol and 2-methoxyoestrone) were not stimulatory. The stimulatory actions of 2-hydroxyoestradiol and testosterone were partially additive and each was antagonized in the same way by the presence of a specific antiandrogen (SCH16423). These observations suggest a role for intrafollicular catechol oestradiol in modulating FSH-stimulated granulosa cell steroidogenesis; its mechanism of action may be similar to that of testosterone.

Restricted access
CK Ho
Search for other papers by CK Ho in
Google Scholar
PubMed
Close
,
M Tetsuka
Search for other papers by M Tetsuka in
Google Scholar
PubMed
Close
, and
SG Hillier
Search for other papers by SG Hillier in
Google Scholar
PubMed
Close

Glucocorticoids are known to have diverse effects on the uterus, generally believed to be mediated by the glucocorticoid receptor (GR). To date, two isoforms of the enzyme 11beta-hydroxysteroid dehydrogenase (11betaHSD) have been identified, namely 11betaHSD1 and 11betaHSD2, which interconvert active and inactive glucocorticoids and regulate local levels of hormones available to the GR in target tissues. The aim of the present study was to examine the uterine expression of 11betaHSD and GR mRNA. The interplay of these parameters is probably an important factor in determining actions of glucocorticoids on the uterus. Using Northern analysis we investigated the uterine expression of 11betaHSD1, 11betaHSD2 and GR mRNA in relation to serum levels of sex steroid hormones and uterine progesterone receptor mRNA expression in an animal model. Immature female rats were treated with 10 IU pregnant mare serum gonadotrophin (PMSG) followed by 10 IU human chorionic gonadotrophin (hCG) 48 h afterwards, and then killed at 0, 3, 6, 9, 12 and 24 h and 5 days after the hCG injection. Expression of both 11betaHSD1 and 11betaHSD2 mRNA in total uterine RNA was found to be up-regulated by more than 50% at 48 h after PMSG injection when oestradiol levels were also high. Following hCG treatment the expression of 11betaHSD1 and 11betaHSD2 further increased to reach maximal levels at 24 and 12 h respectively. GR mRNA expression was down-regulated by more than 50% by PMSG but gradually recovered after hCG injection. The results show that mRNA expression of 11betaHSD1, 11betaHSD2 and GR in the uterus is developmentally regulated, suggesting that these key determinants of glucocorticoid action may play an important role in uterine function.

Free access
M Tetsuka
Search for other papers by M Tetsuka in
Google Scholar
PubMed
Close
,
LC Haines
Search for other papers by LC Haines in
Google Scholar
PubMed
Close
,
M Milne
Search for other papers by M Milne in
Google Scholar
PubMed
Close
,
GE Simpson
Search for other papers by GE Simpson in
Google Scholar
PubMed
Close
, and
SG Hillier
Search for other papers by SG Hillier in
Google Scholar
PubMed
Close

Granulosa cells from preovulatory follicles show increased expression of 11beta-hydroxysteroid dehydrogenase type 1 (11betaHSD1) at the time of ovulation. As ovulation may be an inflammatory process, this may be a mechanism of local enhancement of the activity of anti-inflammatory glucocorticoids. In this study, we examined direct effects of LH, the proinflammatory cytokine, interleukin-1beta (IL-1beta), and pharmacological activators of protein kinase A (PKA) (forskolin and dibutyryl (db) cAMP) and PKC (LH-releasing hormone and phorbol 12-myristate 13-acetate (PMA)) signalling on the expression of 11betaHSD1 mRNA in vitro. Granulosa cells from immature female rat ovaries were cultured (pretreatment) in serum-free medium 199 containing recombinant human (rh) FSH (1 ng/ml) for 48 h to induce responsiveness to LH. Cell monolayers were then washed and cultured (test treatment) for a further 12 h in the presence of rhLH (0-100 ng/ml), IL-1beta (0-50 ng/ml), or both. Total RNA was extracted from granulosa cell monolayers and taken for quantitative ribonuclease protection analysis of 11betaHSD1 mRNA. The low level of 11betaHSD1 mRNA detectable in unstimulated (control) cultures was increased approximately twofold by the 48-h pretreatment with rhFSH. Subsequent exposure to rhLH (1-100 ng/ml) for a further 12 h dose-dependently increased 11betaHSD1 mRNA expression by an additional two- to threefold. Forskolin (10 microM), db-cAMP (2 mM), LH-releasing hormone (LHRH; 1 microM) and PMA (200 nM) were also stimulatory. IL-1beta (0.05-50 ng/ml) stimulated 11betaHSD1 mRNA expression in a dose-related manner, both in the absence and in the presence of rhLH (3 ng/ml). The interaction between IL-1beta (5 ng/ml) and rhLH (3 ng/ml) was additive. Co-treatment with a 50-fold excess of IL-1 receptor antagonist fully reversed the action of IL-1beta. We conclude that 11betaHSD1 mRNA expression in functionally mature granulosa cells is directly stimulated by gonadotrophins and IL-1beta in vitro, potentially involving post-receptor signalling via PKA- and PKC-mediated pathways. Thus both LH and IL-1beta may serve physiological roles in the upregulation of 11betaHSD1 gene expression by granulosa cells in ovulatory follicles.

Free access
S.G. Hillier
Search for other papers by S.G. Hillier in
Google Scholar
PubMed
Close
,
C.G. Tsonis
Search for other papers by C.G. Tsonis in
Google Scholar
PubMed
Close
,
E.J. Wickings
Search for other papers by E.J. Wickings in
Google Scholar
PubMed
Close
, and
K.A. Eidne
Search for other papers by K.A. Eidne in
Google Scholar
PubMed
Close

ABSTRACT

The bioactivity of a synthetic peptide fragment which mimics the N-terminal sequence of the 134-amino-acid porcine Inhibin α-subunit (pl- α1-26-Gly27Tyr28-OH) was tested and compared with the bioactivity of GnRH in rat granulosa cell cultures. Granulosa cells from immature female rat ovaries were cultured with hFSH and testosterone to stimulate the production of cyclic AMP, progesterone and oestradiol. Addition of pl- α1-26-Gly27Tyr28-OH to the culture medium caused a dose-dependent suppression of all three parameters (ID50 700-1,000 nmol/l). GnRH caused similar but higher-potency inhibition (ID50 2-4 nmol/l). Suppression of granulosa cell function by both peptides was fully reversible by a synthetic GnRH antagonist. Moreover, specific binding of the porcine inhibin fragment to ovarian GnRH receptors was demonstrated by radioreceptor assay. This is evidence that the porcine inhibin α-subunit fragment suppresses FSH-induced rat granulosa cell function via a mechanism of action similar to that of GnRH.

Restricted access